Navigation Links
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
Date:9/8/2009

related to ISTA's financial guidance for 2009, the expansion of ISTA's sales force, and ISTA's anticipated devotion of resources toward the marketing of Bepreve, Xibrom and Istalol are forward-looking statements. Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements. These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ from current expectations include, among others, uncertainties and risks regarding market acceptance of and demand for ISTA's approved products; delays and uncertainties related to the FDA or other regulatory agency approval or actions; and such other risks and uncertainties as detailed from time to time in ISTA's public filings with the U.S. Securities and Exchange Commission, including but not limited to ISTA's Annual Report on Form 10-K for the year ended December 31, 2008, and its most recent Quarterly Report on Form 10-Q for the quarter ended June 30, 2009.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
2. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
5. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
6. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
7. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
8. Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
9. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
10. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
11. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... , Aug. 3, 2015  Isis Pharmaceuticals, ... announced a strategic collaboration to discover and develop ... The new collaboration builds on a broad existing ... strategic approach in these therapeutic areas using novel ... extend use of its antisense technology to diseases ...
(Date:7/31/2015)... 2015  In today,s ever-changing marketplace, call centers must ... increasingly connected, and increasingly impatient with slow service. The ... channels and tools is driving call centers to explore ... According to research by benchmarking firm, Best Practices, ... in a call center study realize the impact of ...
(Date:7/31/2015)... 2015 RnRMarketResearch.com adds Syringes ... report that provides an overview of syringes and ... from in-house databases, secondary and primary research. ... products pipeline spread across 124 pages, talking about ... and 5 figures is now available at ...
Breaking Medicine Technology:AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... CHICAGO, Nov. 10 Advanced Life Sciences Holdings, ... engaged in the discovery, development and commercialization of novel ... respiratory diseases, today announced its financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO ) , The net loss ...
... NEW YORK, Nov. 10 Reportlinker.com announces ... available in its catalogue. , The ... Market Outlook , http://www.reportlinker.com/p0158356/The-Global-Drug-Delivery-Market-Research-Trends-and-Market-Outlook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... drug delivery industry has in recent years ...
Cached Medicine Technology:Advanced Life Sciences Announces Third Quarter 2009 Financial Results 2Advanced Life Sciences Announces Third Quarter 2009 Financial Results 3Advanced Life Sciences Announces Third Quarter 2009 Financial Results 4Advanced Life Sciences Announces Third Quarter 2009 Financial Results 5Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6Advanced Life Sciences Announces Third Quarter 2009 Financial Results 7Advanced Life Sciences Announces Third Quarter 2009 Financial Results 8Advanced Life Sciences Announces Third Quarter 2009 Financial Results 9Advanced Life Sciences Announces Third Quarter 2009 Financial Results 10Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 2Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 3Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 4Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 5Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 6Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 7Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 8Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 9Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 10Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook 11
(Date:8/3/2015)... Texas (PRWEB) , ... August 03, 2015 , ... ... an agreement to Seattle-based Genelex to offer pharmacogenetic lab testing and precision ... and reduce health care costs. , Annually, more than 8.6 million adverse ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Dental ... to help patients in need. Most people know that general health emergencies, such as ... a fewer amount of people know where to turn to during a dental emergency. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... ® and Navigant Center for Healthcare Research and Policy Analysis show widespread support ... of respondents said they agreed or strongly agreed that the controversial law passed ...
(Date:8/3/2015)... ... 2015 , ... The U.S. Food and Drug Administration (FDA) recently approved a ... acid, which occurs naturally in the body and helps absorb and breakdown fat cells. ... the body. These are invasive procedures and very expensive for most people. Now with ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has completed ... The acquisition includes all of IBAM NA’s cyclotron sites and research and development facilities. ... regionally located business, as well as a large manufacturing hub in Noblesville, Indiana,” said ...
Breaking Medicine News(10 mins):Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2
... 6 Mergent, Inc., administrator for the,Healthshares(TM) Indexes, ... Exchange Traded Funds, today announced the following,changes with ... May 9, 2008:,Masimo Corporation (Nasdaq: MASI ) ... in the HealthShares(TM) Composite Index, Quest,Diagnostics Inc (NYSE: ...
... Traffic Reached Record Levels of 51.9 Million Unique Monthly Users and ... ... Health Corp. (Nasdaq:,WBMD) today announced financial results for the three months ... quarter, as,WebMD continued to consolidate its position as the leading source ...
... the annual shareholders,meeting of Sigma-Aldrich Corporation (Nasdaq: SIAL ... re-elected: David R. Harvey, W. Lee,McCollum, Jai P. Nagarkatti, ... R. G. Sear, D. Dean Spatz and Barrett A. ... of Medtronic, Inc., was,elected to her first term as ...
... deals another blow to homocysteine theory , , TUESDAY, May ... supplements aimed at reducing blood levels of the amino ... and stroke, a long-term study found. , It,s the ... lowering homocysteine levels could reduce the incidence of cardiovascular ...
... Healthcare Workers Demonstrate to Protect Their Voice & Vote ... The battle,over the direction of the Service Employees International ... of hearings was held to,determine the fate of more ... Workers -- West (UHW). UHW represents 150,000,caregivers in hospitals, ...
... Epitomics, Inc. announced,today that its Hangzhou subsidiary has ... of its novel line of rabbit monoclonal,antibodies. "This ... quality management and ultimately the finest quality,antibodies available ... Yu,President and CEO of Epitomics, Inc., "ISO ...
Cached Medicine News:Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes 2Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes 3Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes 4Health News:WebMD Announces First Quarter Financial Results 2Health News:WebMD Announces First Quarter Financial Results 3Health News:WebMD Announces First Quarter Financial Results 4Health News:WebMD Announces First Quarter Financial Results 5Health News:WebMD Announces First Quarter Financial Results 6Health News:WebMD Announces First Quarter Financial Results 7Health News:WebMD Announces First Quarter Financial Results 8Health News:WebMD Announces First Quarter Financial Results 9Health News:WebMD Announces First Quarter Financial Results 10Health News:WebMD Announces First Quarter Financial Results 11Health News:WebMD Announces First Quarter Financial Results 12Health News:WebMD Announces First Quarter Financial Results 13Health News:WebMD Announces First Quarter Financial Results 14Health News:WebMD Announces First Quarter Financial Results 15Health News:WebMD Announces First Quarter Financial Results 16Health News:WebMD Announces First Quarter Financial Results 17Health News:WebMD Announces First Quarter Financial Results 18Health News:WebMD Announces First Quarter Financial Results 19Health News:WebMD Announces First Quarter Financial Results 20Health News:Sigma-Aldrich Shareholders Elect Directors and Ratify Auditor; Directors Declare Quarterly Dividend 2Health News:Folic Acid Doesn't Help the Heart 2Health News:SEIU Retaliates Against California Caregivers & Democratic Reform Movement 2Health News:Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies. 2
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
The PreFix™ temporary fixator prepares you for any situation that requires rapid stabilization of complex fractures....
Angulation, translation and rotation. A whole different point of view. The Sheffield Ring Fixation System is a design achievement that advances the possibilities of fracture management....
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
Medicine Products: